These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33309687)

  • 21. Mechanisms of action of the antidiabetic peptide [S4K]CPF-AM1 in db/db mice.
    Musale V; Moffett RC; Owolabi B; Conlon JM; Flatt PR; Abdel-Wahab YHA
    J Mol Endocrinol; 2021 Feb; 66(2):115-128. PubMed ID: 33252358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive effects of GLP-1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL/KsJ db/db mice with degenerative diabetes.
    Moffett RC; Patterson S; Irwin N; Flatt PR
    Diabetes Metab Res Rev; 2015 Mar; 31(3):248-55. PubMed ID: 25256010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GABA dramatically improves glucose tolerance in streptozotocin-induced diabetic rats fed with high-fat diet.
    Sohrabipour S; Sharifi MR; Talebi A; Sharifi M; Soltani N
    Eur J Pharmacol; 2018 May; 826():75-84. PubMed ID: 29391158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation and antidiabetic utility of a novel hybrid peptide, exendin-4/gastrin/xenin-8-Gln.
    Hasib A; Ng MT; Khan D; Gault VA; Flatt PR; Irwin N
    Eur J Pharmacol; 2018 Sep; 834():126-135. PubMed ID: 30025814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed mice.
    Irwin N; Hunter K; Montgomery IA; Flatt PR
    Diabetes Obes Metab; 2013 Jul; 15(7):650-9. PubMed ID: 23388064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel GLP-1/xenin hybrid peptide improves glucose homeostasis, circulating lipids and restores GIP sensitivity in high fat fed mice.
    Hasib A; Ng MT; Khan D; Gault VA; Flatt PR; Irwin N
    Peptides; 2018 Feb; 100():202-211. PubMed ID: 29412820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Esculentin-2CHa-Related Peptides Modulate Islet Cell Function and Improve Glucose Tolerance in Mice with Diet-Induced Obesity and Insulin Resistance.
    Ojo OO; Srinivasan DK; Owolabi BO; Vasu S; Conlon JM; Flatt PR; Abdel-Wahab YH
    PLoS One; 2015; 10(10):e0141549. PubMed ID: 26512980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice.
    Pathak NM; Millar PJB; Pathak V; Flatt PR; Gault VA
    Mol Cell Endocrinol; 2018 Jan; 460():200-208. PubMed ID: 28754350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A GIP/xenin hybrid in combination with exendin-4 improves metabolic status in db/db diabetic mice and promotes enduring antidiabetic benefits in high fat fed mice.
    Craig SL; Perry RA; Vyavahare SS; Ng MT; Gault VA; Flatt PR; Irwin N
    Biochem Pharmacol; 2020 Jan; 171():113723. PubMed ID: 31756326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucoregulatory, endocrine and morphological effects of [P5K]hymenochirin-1B in mice with diet-induced glucose intolerance and insulin resistance.
    Owolabi BO; Ojo OO; Srinivasan DK; Conlon JM; Flatt PR; Abdel-Wahab YH
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):769-81. PubMed ID: 27068334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Casitas B-Lineage Lymphoma RING Domain Inhibitors Protect Mice against High-Fat Diet-Induced Obesity and Insulin Resistance.
    Wu M; Sun L; Pessetto ZY; Zang Z; Xie X; Zhong L; Su Q; Zan W; Gao X; Zhao Y; Sun Y
    PLoS One; 2015; 10(8):e0135916. PubMed ID: 26296084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
    Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidiabetic effects and sustained metabolic benefits of sub-chronic co-administration of exendin-4/gastrin and xenin-8-Gln in high fat fed mice.
    Hasib A; Khan D; Craig SL; Gault VA; Flatt PR; Irwin N
    Eur J Pharmacol; 2019 Dec; 865():172733. PubMed ID: 31614140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidiabetic effects of flavonoids from Sophora flavescens EtOAc extract in type 2 diabetic KK-ay mice.
    Yang X; Yang J; Xu C; Huang M; Zhou Q; Lv J; Ma X; Ke C; Ye Y; Shu G; Zhao P
    J Ethnopharmacol; 2015 Aug; 171():161-70. PubMed ID: 26051831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial actions of the [A14K] analog of the frog skin peptide PGLa-AM1 in mice with obesity and degenerative diabetes: A mechanistic study.
    Musale V; Moffett RC; Conlon JM; Flatt PR; Abdel-Wahab YH
    Peptides; 2021 Feb; 136():170472. PubMed ID: 33338546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-hyperglycemic and anti-hyperlipidemic effects of a special fraction of Luohanguo extract on obese T2DM rats.
    Zhang Y; Zhou G; Peng Y; Wang M; Li X
    J Ethnopharmacol; 2020 Jan; 247():112273. PubMed ID: 31586692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidiabetic effect of Lactobacillus casei CCFM0412 on mice with type 2 diabetes induced by a high-fat diet and streptozotocin.
    Chen P; Zhang Q; Dang H; Liu X; Tian F; Zhao J; Chen Y; Zhang H; Chen W
    Nutrition; 2014 Sep; 30(9):1061-8. PubMed ID: 25102821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ghrelin receptor inverse agonists as a novel therapeutic approach against obesity-related metabolic disease.
    Abegg K; Bernasconi L; Hutter M; Whiting L; Pietra C; Giuliano C; Lutz TA; Riediger T
    Diabetes Obes Metab; 2017 Dec; 19(12):1740-1750. PubMed ID: 28544245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel model of type 2 diabetes mellitus based on obesity induced by high-fat diet in BDF1 mice.
    Karasawa H; Nagata-Goto S; Takaishi K; Kumagae Y
    Metabolism; 2009 Mar; 58(3):296-303. PubMed ID: 19217442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.